Doxycycline Monohydrate
Doxycycline Monohydrate is a pharmaceutical drug with 10 clinical trials. Historical success rate of 90.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
90.0%
9 of 10 finished
10.0%
1 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions
Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
Clinical Trials (10)
Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions
Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions
Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10